Lu-177-PSMA-R2
177Lu-PSMA-R2 was developed as patent protected equivalent of 177Lu-PSMA-617. This [...]
177Lu-PSMA-R2 was developed as patent protected equivalent of 177Lu-PSMA-617. This [...]
67Cu-SARTATE (67Cu-SAR-[Tyr3]-Octreotate) is a therapeutic radiolabeled somatostatin analogue of [...]
131I-Metuximab (brand name Licartin) is a radiolabeled murine antibody [...]
131I-Weimeisheng (131I-Tumor Necrosis Therapy mAb injection) is a radiolabeled [...]
90Y-Besilesomab is the therapeutic analogue of the 99mTc-labeled murine [...]
177Lu-DTPA-Omburtamab (177Lu-Burtomab) is a monoclonal murine antibody, targeted against [...]
131I-ICF01012 is a quite old product which eventually entered [...]
177Lu-PNT2002 (formerly 177Lu-PSMA-I&T) is a peptide developed by the [...]
177Lu-RM2 (177Lu-BAY-1017858) is a molecule corresponding to a different [...]
67Cu-SARbisPSMA is a new PSMA targeting drug labeled with [...]